GlucosAlarm Company
GlucosAlarm enables diabetic patients to easily manage their disease to avoid complications. Diabetes is a global epidemic that affects nearly 400 million people at a cost of over $600 billion per year. To properly manage the disease, diabetics must test their glucose levels several times a day, but current testing methods are inconvenient, painful and expensive. GlucosAlarm is a patent-pending glucose sensor that measures sugar levels in urine. It’s placed inside a toilet and is activated through a smartphone application. It´s easy to use, painless and affordable–and it fits naturally into patients’ daily routines, allowing them to manage diabetes and avoid costly complications.
Industry:
P4 Medicine
Headquarters:
Brownsville, Texas, United States
Zip:
1-10
Founded Date:
2013-01-01
Employees Number:
1-10
Acquisitions Number:
2
Investors Number:
2
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Last Funding Date:
Seed
Last Funding Type:
Seed
Register and Claim Ownership